Title: alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship.
Journal: Bioorganic & medicinal chemistry letters 20021104
1878-81-5
33254-93-2
51012-63-6
6322-83-4
91143-71-4
365572-08-3
351344-10-0 | 20-ethyl-1α,6β,14α,16β-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]-aconitane-7,8-diol,2-hydroxy-1,2,3-propanetricarboxylate | AA01EPK4
1228259-70-8 | N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-N-methyl-carbamicacid,1,1-dimethylethylester | AA01EPPZ
2160555-53-1 | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide | AA01EPXB
313669-88-4 | 2-(3-bromo-4-methoxyphenyl)-3-[(4-chlorophenyl)sulfonyl]-thiazolidine | AA01EQ6K | MFCD00825276
905298-84-2 | LIMK1inhibitorBMS4-BMS4 | AA01EQCC | MFCD24387531
1160573-92-1 | 2-Bromo-1,3,5-trichloro-4-fluorobenzene | AA01EQQW | MFCD11845867
1298086-73-3 | 1-Butyl-4-(tetrahydro-pyran-4-yl)-pyridinium chloride | AA01ERWZ | MFCD06637443
150638-33-8 | 1-(Pyridin-3-ylmethyl)-1H-1,2,3-benzotriazole | AA01EU5H | MFCD00963814
1965304-96-4 | 1,3-Bis ((3-(2-tolyl)-1,2,4-oxadiazol)-5-yl)benzene | AA01EUDX | MFCD28166234
2713-62-4 | 2-(Hexafluoro-2-hydroxyisopropyl)aniline | AA01EUKQ | MFCD03425204
Journal: Bioorganic & medicinal chemistry letters20021104